NHS watchdog considers anti hair loss pill to combat alopecia, which affects ... trends now
NHS watchdog considers anti hair loss pill to combat alopecia, which affects ... trends now
Last week European drugs regulators approved daily anti hair loss pill The National Institute for Health and Care Excellence are assessing the drug
View
comments
Adults and teens with the severe hair loss condition alopecia areata could soon be offered a breakthrough medicine that can trigger regrowth in just six months.
Last week the European drugs regulators approved ritlecitinib, and it is currently being assessed by NHS spending watchdog the National Institute for Health and Care Excellence (NICE).
Alopecia areata is one of the more common causes of hair loss and usually begins in childhood or early adulthood. It is caused by the body’s immune system attacking hair follicles, and is characterised by patches of baldness.
But ritlecitinib has been found to reverse the condition in one in
